May 2004
Volume 45, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2004
Murine model of ocular graft versus host disease
Author Affiliations & Notes
  • S.K. Kim
    Ophthalmology Section,
    MD Anderson Cancer Center, Houston, TX
  • F.C. Marini
    Blood and Marrow Transplantation,
    MD Anderson Cancer Center, Houston, TX
  • P.G. Aycox
    Blood and Marrow Transplantation,
    MD Anderson Cancer Center, Houston, TX
  • L.C. Stephens
    Veterinary Medicine & Surgery,
    MD Anderson Cancer Center, Houston, TX
  • S.M. Kornblau
    Blood and Marrow Transplantation,
    MD Anderson Cancer Center, Houston, TX
  • Footnotes
    Commercial Relationships  S.K. Kim, None; F.C. Marini, None; P.G. Aycox, None; L.C. Stephens, None; S.M. Kornblau, None.
  • Footnotes
    Support  CML P01CA49639(PP–4)–9A1
Investigative Ophthalmology & Visual Science May 2004, Vol.45, 4688. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      S.K. Kim, F.C. Marini, P.G. Aycox, L.C. Stephens, S.M. Kornblau; Murine model of ocular graft versus host disease . Invest. Ophthalmol. Vis. Sci. 2004;45(13):4688.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: To describe a murine model of ocular graft vs. host disease (GVHD). Methods: MHC matched transplantation (which mimics HLA matched transplantation) was performed. AKR/J mice (MHC H–2k) received lethal irradiation (9gray) followed by transplantation with 1x107 BM cells without (control) or with 2 or 4x106 splenic lymphocytes from B10.BR donors (MHC H–2k). Controls consisted of 1) untreated AKR/J mice, 2) irradiated but not transplanted mice, and 3) mice transplanted with marrow alone, which should not develop GVHD. Clinically, mice eyes were evaluated before and after the transplant with external exam, Schirmers, and flourescein staining tests. At the time of death or when scarified due to morbidity (typically day 14–35), the lacrimal glands (harderian glands), lids, and the conjunctiva were examined histolopathologically. These animals were also evaluated for systemic GVHD. Results: Mice with GVHD showed clinical features of erythematous lids, increased fluorescein staining on the ocular surface, and decrease in Schirmers. Of the 12 animals with systemic GVHD histopathologically (in the gut, liver, and skin), 10 animals showed findings consistent with ocular GVHD with apoptosis of the lacrimal/harderian glands, meibomian glands, and in the epithelial layer of the conjunctiva. Of the 10 animals positive for ocular GVHD, skin GVHD was always present, but 2 animals were without gut GVHD and 5 animals were without liver involvement. There was also variable degree of organ involvement, which mirrors human systemic and ocular GVHD. Conclusions: A murine model of ocular graft vs. host disease is described. To our knowledge, it is the first murine model of ocular GVHD. Further studies to better characterize this model are ongoing.

Keywords: transplantation • cornea: tears/tear film/dry eye • uveitis–clinical/animal model 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×